The Korean Journal of Laboratory Medicine  2007;27(4):244-247

doi:10.3343/kjlm.2007.27.4.244

A Case of Therapy-Related Acute Monocytic Leukemia following Low-dose of Etoposide Treatment for Hemophagocytic Lymphohistiocytosis.

Young Ik SEO 1 ; Rojin PARK ; Tae Youn CHOI ; Jeung Won SHIN ; Jong Ho WON ; Hee Sook PARK ; Nam Soo LEE ; Duck CHO

Affiliations

+expand

Keywords

Etoposide; Hemophagocytic lymphohistiocytosis; Therapy-related acute leukemia

Country

Republic of Korea

Language

Korean

Abstract

We report a case of therapy-related acute myeloid leukemia after low-dosed topoisomerase II inhibitor (etoposide) treatment for hemophagocytic lymphohistiocytosis (HLH). A 62-yr-old female patient had previously been treated with a HLH-94 protocol containing a low-dose of etoposide (total dose of 300 mg/m2). Thirty-one months later, the patient was admitted to the hematology department with general weakness and upper respiratory infection symptoms. Peripheral blood smear and bone marrow study revealed acute monocytic leukemia. There was no evidence of myelodysplastic syndrome, and a cytogenetic study showed no chromosomal abnormalities.